Bloggers

Lisa Banket
Cofounding Partner/Publisher
VIEW MY COMPLETE PROFILE
Taren Grom
Cofounding Partner/Editor-in-Chief
VIEW MY COMPLETE PROFILE
Heather Hummel
Project Coordinator
VIEW MY COMPLETE PROFILE
Dan Limbach
Producer, Webcast Network
VIEW MY COMPLETE PROFILE
Denise Myshko
Managing Editor
VIEW MY COMPLETE PROFILE
Kim Ribbink
Features Editor
VIEW MY COMPLETE PROFILE
Robin Robinson
Senior Editor
VIEW MY COMPLETE PROFILE
Marah Walsh
Cofounding Partner/New Business Development
VIEW MY COMPLETE PROFILE

PharmaVOICE Editors' Blog

Showing posts with label health care reform. Show all posts
Showing posts with label health care reform. Show all posts

Friday, September 20, 2013

Are You Prepped for a Health Care Hurricane?

Obamacare
Are we prepared for a possible health care storm?
It's hurricane season, and it's also the season of the Patient Protection and the Affordable Care Act. Obviously this directly affects the Pharmaceutical industry. Will it be a Class 5 disaster or a pleasant tropical breeze? We clearly don't know. Predictions abound, and many political factions are posturing and offering their thoughts. Most offer an extreme outlook on one side or the other.

I've visited over a dozen web sites this week looking for some consistency. I scoured news sites, analyst sites, and manufacturer sites, and I still have no clear idea how this will play out. The range of opinions and lack of consensus is downright intimidating. Some say this will revolutionize health care for all Americans. Others say it will be a bumpy ride for years, before we get it right. And still others say it will be the demise of quality health care as we know it.

So here we sit with far more questions than answers. Here are just a few causing loss of sleep in our industry.
  • Will some pharmaceutical companies take a financial hit under the new system, while others benefit?
  • How will it affect our market share?
  • Is our pipeline strategically sound given this new health care reform?
  • How will company health care plans be overhauled under the new plan?
  • Will patients receive better treatment?
  • Will HCPs know how to navigate the system?
  • Will payers be able to process the reimbursements properly and in a timely manner?
I must admit that I don't trust any of the predictions I read. The issues are polarized beyond understanding. This is one instance where we should prepare for the worst and hope for the best. The key here is preparation.

Here are some points every pharmaceutical company should review before the program begins enrolling patients on October 1.
  • Are we prepared to make quick and informative communications to the public?
  • Have we game planned many of the possible issues that may arise?
  • Will we add clarity or chaos to the mix of information?
  • Is our customer service group staffed up and adequately trained?
  • Have our reps been communicating with their HCP clients about the changes under the PPACA?
  • Have we been working with providers and plans to ensure we are in compliance with their new processes?
  • Are our pharmacy customers comfortable with the new processes for receiving and dispensing our products?
What are your thoughts on the PPACA? Leave a comment.


Tuesday, August 21, 2012

Supreme Court Upheld the ACA. What Do You Do Now? Attend Webinar

ACA Health Care Reform
The ACA has broad-reaching ramifications for health care

I've been working very hard on our next webinar. The topic is about how the ACA will affect health care from a pharma/biotech company perspective. It features some exciting new research findings about how physicians, payers, and pharmaceutical companies will have to adjust to the new system. It also details some interesting and valuable patient perceptions you can't get anywhere else.

There is no cost to attend.

Building Winning Strategies in an ACA World: Your Guide to Success in a Value-Driven Market

Date and Time: September 20, 2012 11:00am EST, 4:00pm GMT (60 minutes)

Please take 3 minutes to register for this webinar.

http://bit.ly/WGwebinar

It's informative. It's interactive. You and your peers will participate in live polls and can even submit questions to the panelists for the Q & A session. I'll be your moderator.

The webinar is designed to explain:
  • How the ACA may impact cost-containment pressures, payer accountability and market conditioning
  • What US marketers can learn from EU experiences to help them adapt successfully to ACA
  • How the development and communication of clinical and economic value messages are changing, with the shift toward evidence-based medicine and comparative effectiveness research
  • Why determining value drivers as early as possible in the clinical and commercial development process is critical for any brand
This educational webinar is easily accessed via the Internet.

If you cannot attend the live event, but want to access the OnDemand version, please register now, so that you receive the OnDemand access information via email after the event.

Learn more and register at

http://bit.ly/WGwebinar

I hope to see you online on September 20!